A carregar...

Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden

STUDY OBJECTIVE—To assess whether in an urban population stage at breast cancer diagnosis is related to area of living and to what extent intra-urban differences in breast cancer mortality are related to incidence respectively stage at diagnosis.
DESIGN—National registries were used to identify case...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Manjer, J., Berglund, G., Bondesson, L., Garne, J. P., Janzon, L., Lindgren, A., Malina, J., Matson, S.
Formato: Artigo
Idioma:English
Publicado em: BMJ Group 2000
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1731663/
https://ncbi.nlm.nih.gov/pubmed/10827910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jech.54.4.279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
id pubmed-1731663
record_format dspace
spelling pubmed-17316632008-04-14 Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden Manjer, J. Berglund, G. Bondesson, L. Garne, J. P. Janzon, L. Lindgren, A. Malina, J. Matson, S. J Epidemiol Community Health Research Report STUDY OBJECTIVE—To assess whether in an urban population stage at breast cancer diagnosis is related to area of living and to what extent intra-urban differences in breast cancer mortality are related to incidence respectively stage at diagnosis.
DESIGN—National registries were used to identify cases. Mortality in 17 residential areas was studied in relation to incidence and stage distribution using linear regression analysis. Areas with high and low breast cancer mortality, incidence and proportion of stage II+ tumours at diagnosis were also compared in terms of their sociodemographic profile.
SETTING—City of Malmö in southern Sweden.
PATIENTS—The 1675 incident breast cancer cases and 448 deaths that occurred in women above 45 years of age in Malmö 1986-96.
MAIN RESULTS—Average annual age standardised breast cancer mortality ranged between residential areas, from 35/10(5) to 107/10(5), p=0.04. Mortality of breast cancer was not correlated to incidence, r= 0.22, p=0.39. The ratio of stage II+/0-I cancer incidence varied between areas from 0.45 to 1.99 and was significantly correlated to breast cancer mortality, r= 0.53, p=0.03. Areas with high proportion of stage II+ cancers and high mortality/incidence ratio were characterised by a high proportion of residentials receiving income support, being foreigners and current smokers.
CONCLUSIONS—Within this urban population there were marked differences in breast cancer mortality between residential areas. Stage at diagnosis, but not incidence, contributed to the pattern of mortality. Areas with high proportion of stage II+ tumours differed unfavourably in several sociodemographic aspects from the city average.


Keywords: breast cancer mortality; tumour stage; sociodemographic factors BMJ Group 2000-04 /pmc/articles/PMC1731663/ /pubmed/10827910 http://dx.doi.org/10.1136/jech.54.4.279 Text en
institution US National Library of Medicine
collection PubMed Central
language English
format Article
topic Research Report
spellingShingle Research Report
Manjer, J.
Berglund, G.
Bondesson, L.
Garne, J. P.
Janzon, L.
Lindgren, A.
Malina, J.
Matson, S.
Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden
description STUDY OBJECTIVE—To assess whether in an urban population stage at breast cancer diagnosis is related to area of living and to what extent intra-urban differences in breast cancer mortality are related to incidence respectively stage at diagnosis.
DESIGN—National registries were used to identify cases. Mortality in 17 residential areas was studied in relation to incidence and stage distribution using linear regression analysis. Areas with high and low breast cancer mortality, incidence and proportion of stage II+ tumours at diagnosis were also compared in terms of their sociodemographic profile.
SETTING—City of Malmö in southern Sweden.
PATIENTS—The 1675 incident breast cancer cases and 448 deaths that occurred in women above 45 years of age in Malmö 1986-96.
MAIN RESULTS—Average annual age standardised breast cancer mortality ranged between residential areas, from 35/10(5) to 107/10(5), p=0.04. Mortality of breast cancer was not correlated to incidence, r= 0.22, p=0.39. The ratio of stage II+/0-I cancer incidence varied between areas from 0.45 to 1.99 and was significantly correlated to breast cancer mortality, r= 0.53, p=0.03. Areas with high proportion of stage II+ cancers and high mortality/incidence ratio were characterised by a high proportion of residentials receiving income support, being foreigners and current smokers.
CONCLUSIONS—Within this urban population there were marked differences in breast cancer mortality between residential areas. Stage at diagnosis, but not incidence, contributed to the pattern of mortality. Areas with high proportion of stage II+ tumours differed unfavourably in several sociodemographic aspects from the city average.


Keywords: breast cancer mortality; tumour stage; sociodemographic factors
author Manjer, J.
Berglund, G.
Bondesson, L.
Garne, J. P.
Janzon, L.
Lindgren, A.
Malina, J.
Matson, S.
author_facet Manjer, J.
Berglund, G.
Bondesson, L.
Garne, J. P.
Janzon, L.
Lindgren, A.
Malina, J.
Matson, S.
author_sort Manjer, J.
title Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden
title_short Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden
title_full Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden
title_fullStr Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden
title_full_unstemmed Intra-urban differences in breast cancer mortality: a study from the city of Malmö in Sweden
title_sort intra-urban differences in breast cancer mortality: a study from the city of malmö in sweden
publisher BMJ Group
publisher_facet BMJ Group
publishDate 2000
url https://ncbi.nlm.nih.gov/pmc/articles/PMC1731663/
https://ncbi.nlm.nih.gov/pubmed/10827910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jech.54.4.279
_version_ 1760347266594373632